Therapeutic decisions regarding initiation of antifibrotic therapy in IPF: a multicenter, prospective cohort study from Poland.
K. Górska (Warszawa, Poland), M. Maskey-Warzechowska (Warszawa, Poland), M. Barnas (Warszawa, Poland), A. Bialas (Lodz, Poland), A. Barczyk (Katowice, Poland), H. Jagielska-Len (Zielona Gora, Poland), E. Jassem (Gdansk, Poland), A. Kania (Cracow, Poland), K. Lewandowska (Warsaw, Poland), S. Majewski (Lodz, Poland), M. Martusewicz-Boros (Warsaw, Poland), W. Piotrowski (Lodz, Poland), A. Sieminska (Gdansk, Poland), K. Sladek (Cracow, Poland), M. Sobiecka (Warsaw, Poland), M. Trzaska-Sobczak (Katowice, Poland), W. Tomkowski (Warsaw, Poland), B. Zolnowska (Warsaw, Poland), R. Krenke (Warsaw, Poland)
Source: International Congress 2022 – How to prevent progression in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Górska (Warszawa, Poland), M. Maskey-Warzechowska (Warszawa, Poland), M. Barnas (Warszawa, Poland), A. Bialas (Lodz, Poland), A. Barczyk (Katowice, Poland), H. Jagielska-Len (Zielona Gora, Poland), E. Jassem (Gdansk, Poland), A. Kania (Cracow, Poland), K. Lewandowska (Warsaw, Poland), S. Majewski (Lodz, Poland), M. Martusewicz-Boros (Warsaw, Poland), W. Piotrowski (Lodz, Poland), A. Sieminska (Gdansk, Poland), K. Sladek (Cracow, Poland), M. Sobiecka (Warsaw, Poland), M. Trzaska-Sobczak (Katowice, Poland), W. Tomkowski (Warsaw, Poland), B. Zolnowska (Warsaw, Poland), R. Krenke (Warsaw, Poland). Therapeutic decisions regarding initiation of antifibrotic therapy in IPF: a multicenter, prospective cohort study from Poland.. 2664
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|